Bio-Techne (TECH) Other Non-Current Assets (2010 - 2026)

Bio-Techne (TECH) recorded quarterly Other Non-Current Assets of $264.4 million in Q1 2026, down 1.02% quarter-over-quarter from $267.1 million in Q4 2025, and down 1.72% on a YoY basis from $269.0 million in Q1 2025.

Bio-Techne (TECH) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Bio-Techne's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $264.4 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 1.72% year-over-year to $264.4 million; the TTM figure through Mar 2026 stood at $264.4 million (down 1.72% YoY), while the FY2025 annual figure was $12.3 million, down 95.33% from the prior year.
  • Other Non-Current Assets was $264.4 million for Q1 2026 at Bio-Techne, down from $267.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $285.3 million in Q2 2023 to a low of $1.0 million in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $159.6 million across 5 years, with a median of $264.3 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets sank 96.64% in 2024, then jumped 25409.46% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $53.2 million in 2022, then tumbled by 49.91% to $26.6 million in 2023, then plunged by 96.07% to $1.0 million in 2024, then surged by 25409.46% to $267.1 million in 2025, then slipped by 1.02% to $264.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $264.4 million (Q1 2026), $267.1 million (Q4 2025), and $276.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn 264.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 264.37 Mn
Dec 31, 2025 267.08 Mn
Sep 30, 2025 276.56 Mn
Jun 30, 2025 12.33 Mn
Mar 31, 2025 268.99 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 9.46 Mn
Jun 30, 2024 264.27 Mn
Mar 31, 2024 272.14 Mn
Dec 31, 2023 26.65 Mn
Sep 30, 2023 281.58 Mn
Jun 30, 2023 285.30 Mn
Mar 31, 2023 283.35 Mn
Dec 31, 2022 53.19 Mn
Sep 30, 2022 53.90 Mn
Jun 30, 2022 46.83 Mn
Mar 31, 2022 45.98 Mn
Dec 31, 2021 37.11 Mn
Sep 30, 2021 11.59 Mn
Jun 30, 2021 11.58 Mn